chr4-105234463-C-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001127208.3(TET2):​c.521C>A​(p.Pro174His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,613,938 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 5 hom. )

Consequence

TET2
NM_001127208.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3O:1

Conservation

PhyloP100: 0.908

Publications

23 publications found
Variant links:
Genes affected
TET2 (HGNC:25941): (tet methylcytosine dioxygenase 2) The protein encoded by this gene is a methylcytosine dioxygenase that catalyzes the conversion of methylcytosine to 5-hydroxymethylcytosine. The encoded protein is involved in myelopoiesis, and defects in this gene have been associated with several myeloproliferative disorders. Two variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
TET2-AS1 (HGNC:41125): (TET2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007983297).
BP6
Variant 4-105234463-C-A is Benign according to our data. Variant chr4-105234463-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 135315.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00136 (207/152214) while in subpopulation NFE AF = 0.00237 (161/68006). AF 95% confidence interval is 0.00207. There are 1 homozygotes in GnomAd4. There are 99 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TET2NM_001127208.3 linkc.521C>A p.Pro174His missense_variant Exon 3 of 11 ENST00000380013.9 NP_001120680.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TET2ENST00000380013.9 linkc.521C>A p.Pro174His missense_variant Exon 3 of 11 5 NM_001127208.3 ENSP00000369351.4

Frequencies

GnomAD3 genomes
AF:
0.00136
AC:
207
AN:
152096
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00226
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00237
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00154
AC:
386
AN:
250054
AF XY:
0.00144
show subpopulations
Gnomad AFR exome
AF:
0.000309
Gnomad AMR exome
AF:
0.000696
Gnomad ASJ exome
AF:
0.000798
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00301
Gnomad NFE exome
AF:
0.00243
Gnomad OTH exome
AF:
0.00164
GnomAD4 exome
AF:
0.00121
AC:
1774
AN:
1461724
Hom.:
5
Cov.:
34
AF XY:
0.00118
AC XY:
857
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.000895
AC:
40
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.000612
AC:
16
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39648
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86248
European-Finnish (FIN)
AF:
0.00339
AC:
181
AN:
53384
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00132
AC:
1469
AN:
1111978
Other (OTH)
AF:
0.00108
AC:
65
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
114
227
341
454
568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00136
AC:
207
AN:
152214
Hom.:
1
Cov.:
32
AF XY:
0.00133
AC XY:
99
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41520
American (AMR)
AF:
0.000589
AC:
9
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00226
AC:
24
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00237
AC:
161
AN:
68006
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00183
Hom.:
0
Bravo
AF:
0.00110
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00151
AC:
13
ExAC
AF:
0.00185
AC:
224
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00202
EpiControl
AF:
0.000889

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Other:1
May 04, 2022
Mendelics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

not provided Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TET2: BP4, BS2 -

TET2-related disorder Benign:1
May 20, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.016
.;T;T;T;.
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.69
T;T;T;.;T
M_CAP
Benign
0.052
D
MetaRNN
Benign
0.0080
T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.0
N;.;N;N;.
PhyloP100
0.91
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.57
N;N;N;N;N
REVEL
Benign
0.064
Sift
Benign
0.032
D;D;D;D;D
Sift4G
Benign
0.18
T;T;T;T;T
Polyphen
0.25
B;B;B;B;.
Vest4
0.10
MVP
0.45
MPC
0.10
ClinPred
0.018
T
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.057
gMVP
0.11
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146031219; hg19: chr4-106155620; COSMIC: COSV54426068; API